Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021489
Filing Date
2023-05-12
Accepted
2023-05-12 07:02:53
Documents
96
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q thrn-20230331.htm   iXBRL 10-Q 3769811
2 EX-10.3 thrn-ex10_3.htm EX-10.3 34764
3 EX-31.1 thrn-ex31_1.htm EX-31.1 21690
4 EX-31.2 thrn-ex31_2.htm EX-31.2 21774
5 EX-32.1 thrn-ex32_1.htm EX-32.1 15240
6 EX-32.2 thrn-ex32_2.htm EX-32.2 16084
  Complete submission text file 0000950170-23-021489.txt   16087496

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thrn-20230331_pre.xml EX-101.PRE 765483
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT thrn-20230331_lab.xml EX-101.LAB 1003269
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT thrn-20230331_def.xml EX-101.DEF 605829
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thrn-20230331.xsd EX-101.SCH 137700
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT thrn-20230331_cal.xml EX-101.CAL 97639
90 EXTRACTED XBRL INSTANCE DOCUMENT thrn-20230331_htm.xml XML 3105358
Mailing Address 620 OMNI INDUSTRIAL BLVD. SUMMERVILLE SC 29483
Business Address 620 OMNI INDUSTRIAL BLVD. SUMMERVILLE SC 29483 843-501-0286
Thorne Healthtech, Inc. (Filer) CIK: 0001844280 (see all company filings)

EIN.: 272877253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40826 | Film No.: 23913116
SIC: 2834 Pharmaceutical Preparations